BOD — Bod Science Income Statement
0.000.00%
Last trade - 00:00
HealthcareSpeculativeMicro Cap
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1.34 | 6 | 7.44 | 5.09 | 3.32 |
Cost of Revenue | |||||
Gross Profit | 0.814 | 2.13 | 3.52 | 2.16 | 2.3 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 8.97 | 10.8 | 11.7 | 10.5 | 11.6 |
Operating Profit | -7.62 | -4.78 | -4.26 | -5.41 | -8.26 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -7.62 | -4.82 | -4.23 | -5.41 | -7.95 |
Provision for Income Taxes | |||||
Net Income After Taxes | -7.62 | -4.82 | -4.23 | -5.41 | -7.95 |
Net Income Before Extraordinary Items | |||||
Net Income | -7.62 | -4.82 | -4.23 | -5.41 | -7.95 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -7.62 | -4.82 | -4.23 | -5.41 | -7.95 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.105 | -0.05 | -0.043 | -0.052 | -0.055 |